Medical directoryActive ingredient
Wegovy
The brand name of semaglutide 2.4 mg. It is mentioned as a comparative reference in the STEP-1 trial. NOTE: this is a brand name, not an INN.
Institutional endorsement by Clínica Evolution
Medical guides
Insulin resistance: symptoms, how it is diagnosed and how to reverse it
ReadMounjaro reviews: what the trials show and what patients report
ReadOzempic price in Spain: how much it costs per pen and per month in 2026
ReadOrforglipron (Foundayo), approved by the FDA: the first GLP-1 pill that can be taken without food or water restrictions
ReadWeight regain after stopping treatment: why it happens and how it is managed
ReadOrforglipron (Foundayo): the first GLP-1 pill with no restrictions, and why it isn't available in Spain
ReadRetatrutide: what its phase 3 trial found, and why you can't get hold of it
ReadCagriSema: what it is, what the REDEFINE trials found and why it disappointed
ReadBuying Ozempic and Mounjaro in Spain: how to get them legally and safely
ReadGLP-1: what it is, how it works and why it is transforming obesity treatment
ReadMounjaro vs Ozempic: clinical differences, effectiveness and which one suits you
ReadOzempic in Spain: what it is, how it works and who can take it
ReadHow much does a medical weight loss treatment cost in Spain: complete 2026 guide
Read
Keep reading
This entry is for information. Your case requires an individual medical assessment.